Further Confirmation of Broadly Conserved, Highly Immunogenic Cross-Clade HIV CTL Epitopes for Inclusion in the GAIA HIV Vaccine

Authors

Anne S. De Groot, University of Rhode IslandFollow
Leonard Moise, University of Rhode IslandFollow
O. Koita
K. Sangare
L. Levitz
J. Rozenhal
Z. Koty
K. Tounkara
M. Ardito
C. M. Boyle
M. Rochas
W. Martin

Document Type

Article

Date of Original Version

9-13-2012

Abstract

Poster Presentation From AIDS Vaccine 2012 Boston, MA, USA. 9-12 September 2012

Citation/Publisher Attribution

De Groot, A. S., Moise, L., Koita, O., Sangare, K., Levitz, L., Rozenhal, J., Koty, Z., Tounkara, K., Ardito, M., Boyle, C. M., Rochas, M., & Martin, W. (2012). Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine. Retrovirology, 9(Suppl 2), P295.

Available at: http://dx.doi.org/10.1186/1742-4690-9-S2-P295

Creative Commons License

This work is licensed under a Creative Commons Attribution 3.0 License.